Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11364251 Pharmaceutical formulation

Patent 11364251 was granted and assigned to Semnur Pharmaceuticals, Inc. on June, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Semnur Pharmaceuticals, Inc.

Current Assignee

Semnur Pharmaceuticals, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

June 21, 2022

Patent Application Number

16921628

Date Filed

July 6, 2020

Patent Citations

US Patent 10744144 Pharmaceutical formulation

US Patent 10117938 Pharmaceutical formulation

US Patent 10500284 Pharmaceutical formulation

US Patent 11020485 Pharmaceutical formulation

Patent Citations Received

US Patent 12016867 Methods of treating inflammation and/or pain

0

Patent Primary Examiner

CPC Code

Disclosed are aqueous pharmaceutical compositions which provide sustained released delivery of corticosteroid compounds. The pharmaceutical composition comprises an insoluble corticosteroid; a soluble corticosteroid; and at least one viscosity enhancing agent. Also provided are methods for using the pharmaceutical compositions in an epidural injection, intra-articular injection, intra-lesional injection, or an intra-ocular injection.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11364251 Pharmaceutical formulation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool